What you need to know about newborn bloodspot screening - “heel prick” Information for parents and guardians

Health Service Executive; The National Healthy Childhood Programme

dc.contributor.author	Health Service Executive
dc.contributor.author	The National Healthy Childhood Programme
dc.date.accessioned	2024-07-10T15:45:50Z
dc.date.available	2024-07-10T15:45:50Z
dc.date.issued	2022-01-28
dc.identifier.uri	http://hdl.handle.net/10147/642068
dc.description	In the first week after your baby is born, you will be offered newborn bloodspot screening for your baby. This is often called the ‘heel prick’. Newborn bloodspot screening is an essential part of newborn care. It helps identify babies who may be at high risk of having a rare but serious condition. Most babies who are screened will not have any of these conditions. But for the small number of babies who do, the benefits of screening are enormous. In Ireland, all babies are now screened for: • Cystic fibrosis • Congenital hypothyroidism • Phenylketonuria • Maple syrup urine disease • Homocystinuria • Classical galactosaemia • Glutaric aciduria type 1 • Medium chain acyl CoA dehydrogenase deficiency • Adenosine deaminase deficiency severe combined immunodeficiency	en_US
dc.language.iso	en	en_US
dc.publisher	Health Service Executive	en_US
dc.rights	Attribution 4.0 International	*
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	*
dc.subject	HEALTH PROMOTION	en_US
dc.subject	public health	en_US
dc.subject	NEWBORN SCREENING	en_US
dc.subject	Newborn health	en_US
dc.title	What you need to know about newborn bloodspot screening - “heel prick” Information for parents and guardians	en_US
dc.type	Patient Information Leaflet	en_US
refterms.dateFOA	2024-07-10T15:45:52Z